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Laboratory of Molecular Genetics, Institut de Recherches Scientifiques sur le Cancer, B. P. no. 8, 94801 Villejuif, France We analysed the DNA rearrangements that occurred during the integration and amplification of an EpsteinBarr virus (EBV)-simian virus 40 (SV40) hybrid shuttle vector in human cells. The human HeLa cell line was episomally transformed with the EBV-SV40 p205-GTI plasmid. After a 2 month culture in a selective medium, a HeLa cell-derived population (H-G1 cells) was obtained in which the p205-GTI vector was integrated as a single intact copy deleted in the EBV latent origin of replication (OriP) . Sequencing data showed that the endpoints of the plasmid sequences, at the plasmid-cell DNA junctions, are located within the two essential elements of EBV OriP, which may form several secondary structures. This result suggests that a specific DNA sequence (OriP) or palindromic structures could play a role in this integration process. This represents the first fully characterized site of integration of an EBV vector in human cells. The transient expression of the SV40 large T antigen in H-G 1 cells leads to the appearance of episomal molecules with an extremely heterogeneous size pattern. Individual analysis of these episomes after rescue in bacteria indicated that they retained sequences of both the p205-GTI plasmid and cellular DNA. Comparison of the structure of these circular DNAs with those of the integrated p205-GTI copy indicated that large T antigen expression in human cells leads to the amplification of the integrated shuttle vector according to the 'onion skin' model developed for transformed rodent cells. Indeed, amplified sequences were collinear with the integrated p205-GTI copy and its surrounding cellular sequences, distributed almost equally around the SV40 replication origin, and circularized by illegitimate recombination which did not involve specific nucleotide sequences.
Introduction
In mammalian cells, chromosomal rearrangements often produce dramatic genotoxic consequences, resulting in the appearance of genetic diseases and cancer (Croce, 1987) . Recombination mechanisms requiring little or no sequence homology (illegitimate recombination) seem to be involved in most DNA rearrangements (Roth & Wilson, 1988) , including gene amplification (Stark et al., 1989) , deletion formation (Nalbantoglu et al., 1986) and translocation (Meuth, 1989) . Studies on intermolecular recombination between extrachromosomal substrates (Brouilette & Chartrand, 1987) , or at the sites of viral DNA integration (Mounts & Kelly, 1984; Murnane et al., 1990; Romani et al., 1990; Ruley & Fried, 1983; Skalka, 1989) or during gene replacement by targeted recombination of chromosomal DNA with foreign DNA (Roth & Wilson, 1988; Zheng & Wilson, 1990) reveal that DNA rearrangements arising by illegitimate recom-0001-0750 © 1992 SGM bination appear to be much more frequent than those due to homologous recombination in mammalian cells. The majority of these data have been obtained using rodent or simian cells, so little is known about the genetic and biochemical mechanisms involved in illegitimate recombination processes in human cells. Therefore, the development of easily manipulable systems to clone recombination junctions generated in human cells would be desirable to identify sequences involved directly in the recombination process, and to determine whether some sequences are more prone to illegitimate recombination.
We have previously described a shuttle vector system characterized by a high frequency of illegitimate recombination in the human adenovirus-transformed cell line 293 (Stary et al., 1989) . This system consists of an Epstein-Burr virus (EBV)-simian virus 40 (SV40) hybrid replicon (p205-GTI) maintained as an EBV episomal plasmid which can replicate transiently by the SV40 mode in the presence of the SV40 large T antigen. In 293 cells stably carrying the p205-GTI plasmid as an EBVbased vector over a period of several months the production of rearranged molecules derived from the initial vector by illegitimate recombination is observed after the induction of the SV40 replication mode (Stary et al., 1989) . Recovery of these recombinant plasmids from human cells followed by bacterial transformation allowed us to establish a detailed structure for each recombinant molecule, and to sequence several recombination junctions.
Using the p205-GTI system, we constructed a cell line for studying the recombination events involved in plasmid integration, viral amplification and excision of integrated sequences. The human HeLa cell line was transformed with the p205-GTI shuttle vector. After propagation in selective medium for 2 to 5 months, a HeLa cell-derived population was obtained in which transient expression of the SV40 large T antigen leads to the production of a heterogeneous population of recombinant plasmids. These recombinant molecules were individually analysed after rescue in bacteria. We found that they were derived from a unique integrated copy of the p205-GTI plasmid, including the flanking cellular sequences. Sequences involved in the integration process before SV40 large T antigen expression were determined, and we compared the structure of the excised molecules with that of their parental integrated sequence. This paper reports for the first time the molecular structure of an integrated EBV vector in human cells and proposes an easy way to analyse individual recombinant molecules produced in human cells during viral gene amplification.
Methods
Cell cultures. HeLa (human epithelioid cervical carcinoma) cells were transfected with 10 ~tg of intact p205-GTI plasmid (Fig. I a) , described previously (Stary et al., 1989) , in a 50 mm dish by the calcium phosphate method (Wigler et al., 1978) . Two days after transfection, cells were plated in selective medium containing 500 ~tg/ml G418 (Gibco). Cell cultures were maintained at this concentration of G418 in Dulbecco's modified Eagle's medium supplemented with 10% foetal calf serum, fungizone and antibiotics (streptomycin and penicillin). The induction of the SV40 replication mode was initiated by transfection with 10 pg of pKMT11 plasmid (Gerard & Gluzman, 1985) per 50 mm dish by calcium phosphate coprecipitation, or after infection with SV40 (2.5 × 106 p.f.u./ml) as described previously (Menck et al., 1987) .
Plasmid recovery and DNA analysis. Low Mr DNA was purified from cells by a small-scale alkaline lysis method. Cells (10 6 to 107) were pelleted in an Eppendorf tube and resuspended in 0.1 ml 50 mMglucose, 25 mM-Tris-HCl pH 8.0, 10 mM-EDTA, followed by the addition of 0-2 ml 0-2 M-NaOH, 1% SDS. After 5 min at room temperature, 0-15 ml 8 M-ammonium acetate was added and the mixture was incubated for 15 min at 4 °C. After centrifugation for 15 min, the supernatant was collected and a 0.6 volume of isopropanol was added. DNA was precipitated after 5 min at room temperature, and then centrifuged at 4 °C for 15 min, washed with cold 70% ethanol, vacuum-dried, dissolved in 50 ~tl TE buffer (10 mM-Tris-HCl, 1 mM-EDTA) and treated with 10 ~tg/ml DNase-free RNase A for 30 min at 37 °C.
High Mr DNA was isolated from 107 cells. Cells were lysed by the addition of 0.6% SDS, 100 mM-NaCI, 50 mM-Tris-HCl pH 8, 20 mM-EDTA and 100 ~tg/ml DNase-free RNase. The extract was incubated overnight at 37 °C and then digested with 100 ~tg/ml proteinase K for at least 10 h at 37 °C. This solution was extracted twice with phenol and once with chloroform-isoamyl alcohol (24 : 1, v/v). The aqueous phase was dialysed overnight against 10 mM-Tris-HCl pH 8, 1 mM-EDTA, 1 M-NaCI and then overnight against TE buffer. DNA extracts were analysed by Southern blotting as described previously (Stary et al., 1989) .
Rescue analysis of shuttle vector. Low Mr DNA isolated from cells by the alkaline lysis method was introduced into the recombinationdeficient Escherichia coli strain DH5ct (Bethesda Research Laboratories) by the method of Hanahan (1983) . Transformants were selected on LB agar medium containing 100 ~tg/ml ampicillin (Sigma) or 30 ~tg/ml kanamycin (Gibco). Plasmid DNA was purified as described above and analysed using restriction enzymes (New England BioLabs). Digestion products were run on 0.6% agarose gels and analysed by Southern blotting, followed by hybridization with specific oligonucleotide probes labelled to a high specific activity using T4 polynucleotide kinase and [),-32p]ATP (6000 Ci/mmol). DNA sequencing was performed by the chain elongation termination method on dsDNA templates using specific oligonucleotides as primers.
Results
The p205-GTI plasmid (Fig. 1 a) was transfected into human HeLa cells. Two weeks later, a transformed cell population (H-G1 cells) was established by G418 selection. The maintenance of the p205-GTI plasmid as an episomal vector and the ability of H-G1 cells to produce recombinant molecules after the introduction of SV40 large T antigen were studied over a 5 month period. As described previously (Stary et al., 1989) , the SV40 large T antigen could be provided either by transfection of a non-replicating vector expressing the SV40 large T antigen sequence (pKMTll plasmid) or by infection with SV40. In agreement with Heinzel et al. (1988) , we refer to this strategy as the T antigen boost. At 28, 40, 88, 105, 111 and 150 days after the p205-GTI transfection, fractions of the same H-G 1 cell culture were plated on 50 mm dishes and 2 days later, subjected to the T antigen boost or left untreated. After 3 days, extrachromosomal DNA was recovered and analysed by Southern blotting after hybridization with p205-GTI plasmid as probe. Low Mr DNA preparations from ceils were also used to transform bacteria. Plasmids isolated from kanamycinresistant colonies were then individually analysed on agarose gels.
Until 88 days, in the absence of the large T antigen, extrachromosomal DNA in H-GI cells corresponds to the intact p205-GTI plasmid, with a copy number/cell estimated to be around 150. T antigen boost led to an 18-fold amplification of the intact p205-GTI plasmid. 
However, from 88 days after transfection and in the absence of the large T antigen, repeated bacterial transformation and Southern blotting experiments with
low Mr D N A from H-G1 cells failed to detect the episomal p205-GTI vector (data not shown). In contrast, bacterial colonies were isolated after transformation with plasmids rescued from H-G 1 cells submitted to T antigen boost on days 88, 105, 111 or 150, posttransfection. DNA analysis on agarose gels revealed a very heterogeneous population of molecules spanning a range in size from 4300 to 12300 bp. From 11 independent T antigen boost experiments, we isolated 124 plasmids which were then digested with various restriction enzymes. Only three of the 124 plasmids exhibited a restriction pattern identical to that of the p205-GTI plasmid. Five additional vectors were identified as simple deleted forms of p205-GTI and 116 of the 124 plasmids were recombinant molecules exhibiting a striking and new PvulI restriction pattern, as shown in Fig. 2 . Three new PvulI fragments (Fig. 2) were common to most of the recombinant plasmids. The same PvulI restriction pattern was observed whatever the mode of A. Stary and A. Sarasin introduction of the T antigen gene (transfection or infection) and whatever the age of the H-G1 cell line (88, 105, 111 or 150 days).
To characterize precisely the nature of the recombinant molecules, the new 503, 713 and 980 bp PvulI fragments purified from one recombinant plasmid were subcloned into the EcoRV-digested Bluescript plasmid. Sequence analysis revealed that the 980 bp and the 503 bp PvulI fragments corresponded to a sequence which was not present in the p205-GTI plasmid. However, these fragments contained a human repeat sequence identified as a member of the human Alu family interspersed repeat exhibiting 80~ identity with a BLUR8 clone. This result indicated that the isolated recombinant plasmids contained human genomic sequences associated with the original p205-GTI plasmid. No other significant homology with known human sequences was found.
Since recombination events occurred between the p205-GTI plasmid and cellular DNA, the structure of the plasmid in the H-G 1 cells before the T antigen boost was investigated. Restriction mapping followed by hybridization with specific probes was performed on the high Mr DNA from 5-month-old H-G1 ceils. As shown in Fig.  1 (b) , the plasmid sequence consists of a single nearly intact copy of the p205-GTI plasmid integrated into the cellular genome. Only a short region of the EBV origin of replication (OriP) has not been conserved in the integrated state. A unique 9000 bp fragment was detected after digestion with BamHI, which does not cut within the p205-GTI plasmid. The integrated form has retained active bacterial portions of the p205-GTI plasmid, so we assumed that the BamHI fragment containing both the integrated copy of p205-GTI and its flanking genomic sequences could be rescued in bacteria after ligation in vitro. Indeed, restriction enzyme digestion and nucleotide sequencing of several clones obtained after bacterial transformation with the ligation product of BamHI fragments of total nuclear DNA ( Fig.  1 b, C2 ) confirmed the map of the genomic region containing the p205-GTI sequence (Fig. l b) and revealed two plasmid DNA-cell DNA junctions (Fig.  1 b, PC J1 and PC J2). The nucleotide sequence of PCJ1 indicated that the plasmid sequence at the cross-over point corresponded to nucleotide 7451 of the sequence of the B95-8 strain of EBV (Baer et al., 1984) . This sequence is located near the FR region, one of the two essential parts of EBV OriP (Reisman et al., 1985) . The p205-GTI plasmid sequence involved in PC J2 is within the region of dyad symmetry, the other essential part of EBV OriP (Reisman et al., 1985) . The cross-over point corresponded to nucleotide 9074 of the sequence of the B95-8 strain of EBV (Baer et al., 1984) .
Finally, we compared the structure of the integrated Fig. 3 . Sequences of some recombination junctions involved in the circularization of the recombinant molecules. Eight recombination junctions from 45 sequences were randomly selected. Each junction is identified by the recombinant plasmid number and the nucleotide sequences of the parental DNAs involved at the cross-over point. The underlined sequences were recovered from recombinant molecules and an asterisk indicates common nucleotides. Nucleotides in bold are identical in both parental DNAs.
copy of p205-GTI with that of extrachromosomal DNA generated after independent T antigen boost experiments carried out after both pKMT11 transfection and SV40 infection. Using restriction enzyme digestion, hybridization with specific oligonucleotide probes and nucleotide sequence analysis we established a detailed physical map of 80 recombinant molecules and found that 61 exhibited a different restriction map (as illustrated in Fig. 2 ) due only to one fragment of variable size. Alignment of the integrated copy of p205-GTI with the 61 recombinant plasmid physical maps revealed no divergence, as shown for some examples in Fig. 1 (c) . All recombinant molecules were exactly collinear with their parental integrated DNA and retained sequences located to each side of the SV40 origin of replication. In addition, for all recombinant vectors spanning the plasmid DNAcell DNA junctions, the nucleotide sequence of PCJ1 and PC J2 was exactly conserved. These results showed that the recombined molecules were generated by a simple intramolecular end joining of linear molecules that were released from the chromosome after the T antigen boost. Thus the heterogeneity arose from the sites at which recombination took place. Forty-five recombinant junctions from the joining of the two extremities were sequenced. A large variety of sequences involved at the cross-over point was observed, no predominant nucleotide sequence being found. As shown in Fig. 3 for eight independent plasmids, the recombination process occurred between parental DNA sequences having no more than four identical nucleotides.
Discussion
We have developed a shuttle vector system which can be maintained in human HeLa cells over long periods. The novelty of this work lies in the molecular information provided about the sites of integration of an EBV vector in human cells. The use of the shuttle vector also allowed us to isolate individual recombinant molecules readily owing to SV40 large T antigen amplification. Each isolated plasmid gave information on the illegitimate recombination site. Our results show that the p205-GTI plasmid is integrated into HeLa cells as a single copy deleted at the EBV latent origin of replication (Fig. 1 b) . The single integration site has been confirmed by in situ hybridization using the p205-GTI sequence as a probe (Dr A. Aurias & Dr F. Apiou, personal communication). The two regions of the p205-GTI plasmid involved in the integration site lie in EBV OriP, the dyad symmetry region (PC J2) and the family repeat region (PCJ 1). Since EBV vectors replicate episomally in human cells there is no reason for selective pressure to disrupt one of the two functions essential for episomal replication. On the other hand these two regions may form several alternative secondary structures (Karlin, 1986) , one of which is shown in Fig. 4 . Although there is no direct evidence that this structure exists in vivo, several studies have led to the identification of palindromes adjacent to recombination sites in mammalian cells (Hyrien et al., 1987 (Hyrien et al., , 1988 Krawinkel et al., 1986; Nalbantoglu et al., 1986; Nicholls et al., 1987) . Therefore we speculate that the two regions of OriP that can form a large hairpin structure by intrastrand base pairing could play a role in the integration process. These cruciform structures could constitute a better target for recombinases owing to a local, more open configuration of the plasmid DNA resulting in local binding of several EBV nuclear antigen 1 (EBNAI) molecules (Rawlins et al., 1985; Reisman et al., 1985) . Although the intervention of the EBNA1 protein in the integration process remains speculative, EBNAl-binding sites are present at the two recombination sites (Fig. 4) . In addition, multiple single-stranded structures have been detected recently within the OriP region (Orlowski & Miller, 1991) . This reinforces our hypothesis of the existence of an open configuration in the p205-GTI plasmid. Therefore, it is possible that the OriP region of EBV could correspond to a recombination hot spot in human cells which promotes integration. In contrast to what has been proposed in the past, EBV appears to persist in the episomal form infrequently, mainly persisting in the integrated form (Hurley et al., 1991) . Our results provide the first report of the sequences involved in integration. The mechanism involved in the development from H-G 1 cells carrying . Putative secondary structure of the p205-GTI sequences involved in the integration process. The shaded region designates the p205-GTI sequences kept in the integrated copy. The arrows indicate the two plasmid DNA--cell DNA integration sites. Numbers correspond to the nucleotide position on the EBV genome (Baer et al., 1984) . Boxed regions indicate EBNAl-binding sites. These sites were found by the identification of the consensus high affinity site for EBNA1 determined by Ambinder et al. (1990) for the region of PC J1, and according to Rawlins et al. (1985) for the region of PC J2. the p205-GTI as an episome on day 40 to an apparently clonal population containing a unique integrated copy at 88 days is not clear. H-G1 cells correspond to the pool of transfected cells, so it is possible that the integration event may give rise to some kind of selective advantage to the cell in which this rearrangement takes place. Episomal recombinant molecules produced in H-G1 cells after the introduction of the SV40 large T antigen correspond to the products of excision from genomic DNA of p205-GTI and its surrounding cellular sequences. According to the 'onion skin' model, bidirectional reiterated replication from the SV40 origin followed by a single recombination event leads to the cyclization of the amplified molecules in rodent cells (Botchan et al., 1979 (Botchan et al., , 1980 . This model could explain the structure of our recombinant molecules (Fig. 1 c) . These molecules are isolated immediately after the T antigen boost, therefore we propose that the rearrangement we observed reflects the very early recombination events during the initial steps of virus amplification in human cells. Since recombinant plasmids remain collinear with the integrated form, we conclude that the initial step in virus amplification in human cells is not associated with direct complex rearrangements of replicated molecules, but with a single intermolecular joining of the two extremities of amplified molecules. As shown by sequence analysis of the recombination junctions, a process of illegitimate recombination is used to join sequences from both extremities of the amplified molcules. Since no predominant nucleotide sequence was found at these joining sites and since each T antigen boost experiment produced a wide diversity of recombined molecules, we conclude that this recombination process is not sequence-dependent.
In conclusion, the ability of the p205-GTI plasmid system to generate recombinant plasmids is not specific to a unique human cell line because production of recombined molecules is observed in both HeLa and 293 cells (StarT et al., 1989) . It would be possible to use this system to investigate DNA rearrangements in human DNA repair-deficient cells. The p205-GTI plasmid system is suitable for use as a probe to study the fragile sites in the human genome that are more prone to foreign sequence integration, and to investigate in detail the recombination properties of EBV OriP. Since T antigen boost allows the recovery of the integrated vector and flanking cellular DNA in an episomal state without complex rearrangement and its direct cloning into rescued bacterial colonies, the p205-GTI system appears to be an original method for investigating the molecular processes leading to early DNA rearrangements in human cells.
